Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT

v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance at Mar. 31, 2022 $ (143,737) $ 605 $ 624,805 $ (767,724) $ (1,423)
Beginning balance (in shares) at Mar. 31, 2022   60,433,000      
Increase (Decrease) in Stockholders' Equity          
Net loss (8,303)     (8,303)  
Foreign currency translation adjustments, net (2,574)       (2,574)
Shares issued under employee stock purchase plan 472 $ 3 469    
Shares issued under employee stock purchase plan (in shares)   300,000      
Shares issued under employee incentive plans, net 0 $ 14 (14)    
Shares issued under employee incentive plans, net (in shares)   1,425,000      
Shares issued in connection with rights offering, net (in shares)   30,000,000      
Shares issued in connection with rights offering, net 66,250 $ 300 65,950    
Stock-based compensation 5,357   5,357    
Ending balance at Sep. 30, 2022 $ (82,535) $ 922 696,567 (776,027) (3,997)
Ending balance (in shares) at Sep. 30, 2022 92,158,000 92,158,000      
Beginning balance at Jun. 30, 2022 $ (76,499) $ 907 693,896 (768,603) (2,699)
Beginning balance (in shares) at Jun. 30, 2022   90,606,000      
Increase (Decrease) in Stockholders' Equity          
Net loss (7,424)     (7,424)  
Foreign currency translation adjustments, net (1,298)       (1,298)
Shares issued under employee stock purchase plan 471 $ 2 469    
Shares issued under employee stock purchase plan (in shares)   300,000      
Shares issued under employee incentive plans, net 0 $ 13 (13)    
Shares issued under employee incentive plans, net (in shares)   1,252,000      
Rights offering expenses (72)   (72)    
Stock-based compensation 2,287   2,287    
Ending balance at Sep. 30, 2022 $ (82,535) $ 922 696,567 (776,027) (3,997)
Ending balance (in shares) at Sep. 30, 2022 92,158,000 92,158,000      
Beginning balance at Mar. 31, 2023 $ (84,369) $ 936 702,370 (786,094) (1,581)
Beginning balance (in shares) at Mar. 31, 2023 93,574,000 93,574,000      
Increase (Decrease) in Stockholders' Equity          
Net loss $ (12,473)     (12,473)  
Foreign currency translation adjustments, net (471)       (471)
Shares issued under employee incentive plans, net 0 $ 20 (20)    
Shares issued under employee incentive plans, net (in shares)   1,945,000      
Warrants issued in connection with debt refinancing 49   49    
Stock-based compensation 2,831   2,831    
Ending balance at Sep. 30, 2023 $ (94,433) $ 956 705,230 (798,567) (2,052)
Ending balance (in shares) at Sep. 30, 2023 95,519,000 95,519,000      
Beginning balance at Jun. 30, 2023 $ (91,321) $ 938 704,309 (795,236) (1,332)
Beginning balance (in shares) at Jun. 30, 2023   93,705,000      
Increase (Decrease) in Stockholders' Equity          
Net loss (3,331)        
Foreign currency translation adjustments, net (720)       (720)
Shares issued under employee incentive plans, net 0 $ 18 (18)    
Shares issued under employee incentive plans, net (in shares)   1,814,000      
Stock-based compensation 939   939    
Ending balance at Sep. 30, 2023 $ (94,433) $ 956 $ 705,230 $ (798,567) $ (2,052)
Ending balance (in shares) at Sep. 30, 2023 95,519,000 95,519,000